Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Mostrar otras versiones (1)

In 2009, vinflunine was introduced as a second-line treatment to be used after the failure of platinum therapy in patients with metastatic urothelial carcinoma (mUC). The present study investigated the administered vinflunine to patients with mUC in standard clinical practice with the aim of evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmsten, Karin, Dohn, Line, Jensen, Niels Viggo, Shah, Carl-Henrik, Jäderling, Fredrik, Pappot, Helle, Ullén, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950730/
https://www.ncbi.nlm.nih.gov/pubmed/27446429
http://dx.doi.org/10.3892/ol.2016.4775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950730/
https://www.ncbi.nlm.nih.gov/pubmed/27446429
http://dx.doi.org/10.3892/ol.2016.4775

Ejemplares similares